产品分类
Product Category详细介绍
| 品牌 | absin | CAS | 159138-80-4 |
|---|---|---|---|
| 分子式 | C12H17N3O3S | 纯度 | 99% |
| 分子量 | 283.3467 | 货号 | abs47027959 |
| 规格 | 2mg | 供货周期 | 现货 |
| 主要用途 | inhibitory effects on the degranulation | 应用领域 | 化工,生物产业,农林牧渔,制药/生物制药,综合 |
Cariporide 159138-80-4
| 产品描述 | |
| 描述 | Cariporide (HOE-642), a potent NHE1 inhibitor, has inhibitory effects on the degranulation of human platelets, the formation of platelet-leukocyte-aggregates, and the activation of the GPIIb/IIIa receptor (PAC-1). |
| 纯度 | 99% |
| 储存/保存方法 | Store at -20℃ for one year(Powder);Store at 2-4℃ for two weeks;Store at -20℃ for six months after dissolution. |
| 基本信息 | |
| 可溶性/溶解性 | Soluble in DMSO |
| 生物活性 | |
| 靶点 | Sodium Channel |
| In vitro(体外研究) | Cariporide significantly suppresses markers of cell death, such as TUNEL positivity and caspase-3 cleavage, at 8 or 16 hours. Cariporide remarkably suppresses cytosolic Na+ and Ca2+ accumulation. Cariporide prevents mitochondrial membrane potential loss induced by H2+O2+. Cariporide (HOE-642) ameliorates myocardial ischemia/reperfusion injury, by the well-established reduction of cytosolic Ca2+ in cardiac myocytes through inhibition of Na+/H+ exchange. Cariporide (HOE-642), has inhibitory effects on the degranulation of human platelets, the formation of platelet–leukocyte-aggregates, and the activation of the GPIIb/IIIa receptor (PAC-1). |
| In vivo(体内研究) | Intravenous administration of cariporide significantly decreases brain Na+ uptake and reduces cerebral edema, brain swelling, and infarct volume. |
| 参考文献 | |
| 参考文献 |
|
| 研究领域 | |
| 研究领域 | Cardiovascular Immunology CancerTumor biomarkers Drug DiscoverySmall Molecule DrugLead Compound Discovery |
产品咨询